Beata Ambroziewicz: Patient Concerns About Biosimilars

March 29, 2019

Beata Ambroziewicz, president of the Polish Union of Patient Organizations and board member of the Polish Cancer Patient Coalition, discusses patients' concerns about biosimilars and the need for more education about switching.

Transcript:

Concerns are mainly focused on switching from original to biosimilar, not only in terms of safety, or whether this treatment is good for me, but more it comes from a lot of misleading information and not enough contact with doctors. We are not discussing enough the issue of switching. Patients are getting to know that they were switched after [the fact]. It causes a lot of questions: why is the process not transparent enough? We really focus on patient education, and we’re trying to prepare different materials that everyone can educate themselves when patients start biological treatment.